COVID-19 Vaccine Group (with Pfizer, Moderna, and Janssen Vaccines)
Note - The COVID-19 Vaccine Group is based on the interim recommendations from ACIP. As additional guidelines are published, the COVID-19 logic in ICE will be updated. This release includes support for the following COVID-19 vaccines:
- Pfizer COVID-19 vaccine (CVX 208)
- Moderna COVID-19 vaccine (CVX 207)
- Janssen COVID-19 vaccine (CVX 212)
- COVID-19, Unspecified Formulation (CVX 213)
Two Shot Same Day Exception Rules for COVID-19
The Duplicate Shot, Same Day rules do not apply for COVID-19 Vaccine Group, due to the fact that the absolute minimum intervals between dose 1 and dose 2 = 0 days in both the Pfizer COVID-19 2-dose Series and Moderna COVID-19 2-dose Series.
COVID-19 Vaccine Group Evaluation and Forecasting Rules
General Rules for COVID-19
General rules are not series-specific; general rules apply to the entire vaccine group.
COVID-19 Vaccines
CVX Code | Name | Absolute Minimum Age |
---|---|---|
207 | Moderna COVID-19 Vaccine | 0 days |
208 | Pfizer COVID-19 Vaccine | 0 days |
212 | Janssen COVID-19 Vaccine | 0 days |
213 | SARS-COV-2 (COVID-19) vaccine, UNSPECIFIED | 0 days |
(*) If a COVID-19 vaccine is administered before the vaccine's minimum age or series' recommended age (16y - 4d for Pfizer; 18y - 4d for Moderna), or below the series' minimum interval, supplemental text is returned to alert the user of this fact even though the may have been evaluated as Valid. See "Series Special Rules" for all series below for more details. (Note: the running distribution must have the output_supplemental_text option enabled for the supplemental text to be returned.)
Combination Vaccines that Include COVID-19
No combination vaccines exist, at this time, that include COVID-19 and count toward completion of the Pfizer COVID-19 2-dose series.
Immunization Series and Selection Rules
Immunization Series: Pfizer COVID-19 2-dose Series
The Pfizer COVID-19 2dose series is complete after 2 doses.
Vaccine Dose Parameters - Minimum and Routine Ages
Dose | Series Name | Absolute Minimum | Minimum Age | Routine | Latest Recommended Age (less than) | Valid CVX Code(s) per Dose for this Series | Invalid CVX Code(s) per Dose for this Series |
---|---|---|---|---|---|---|---|
1 | Pfizer COVID-19 2-dose Series | 0 days | 16 years | 16 years | N/A | 208, 213 | N/A |
2 | Pfizer COVID-19 2-dose Series | 0 days | 16 years | 16 years | N/A | 208, 207, 213 | N/A |
Vaccine Dose Parameters - Minimum and Recommended Intervals
Doses | Series Name | Absolute Minimum Interval | Minimum Interval | Minimum Recommended Interval | Latest Recommended Interval (less than) |
---|---|---|---|---|---|
Dose 1 to 2 | Pfizer COVID-19 2-dose Series | 0 days | 21 days | 21 days | N/A |
Immunization Series: Moderna COVID-19 2-dose series
The Moderna COVID-19 2-dose series is complete after 2 doses.
Vaccine Dose Parameters - Minimum and Routine Ages
Dose | Series Name | Absolute Minimum | Minimum Age | Routine | Latest Recommended Age (less than) | Valid CVX Code(s) per Dose for this Series | Invalid CVX Code(s) per Dose for this Series |
---|---|---|---|---|---|---|---|
1 | Moderna COVID-19 2-dose Series | 0 days | 18 years | 18 years | N/A | 207, 213 | N/A |
2 | Moderna COVID-19 2-dose Series | 0 days | 18 years | 18 years | N/A | 207, 208, 213 | N/A |
Vaccine Dose Parameters - Minimum and Recommended Intervals
Doses | Series Name | Absolute Minimum Interval | Minimum Interval | Recommended Interval | Latest Recommended Interval (less than) |
---|---|---|---|---|---|
Dose 1 to 2 | Moderna COVID-19 2-dose Series | 0 days | 28 days | 28 days | N/A |
Immunization Series: Janssen COVID-19 1-dose Series
The Janssen COVID-19 1-dose Series is complete after 1 dose.
Vaccine Dose Parameters - Minimum and Routine Ages
Dose | Series Name | Absolute Minimum | Minimum Age | Routine | Latest Recommended Age (less than) | Valid CVX Code(s) per Dose for this Series | Invalid CVX Code(s) per Dose for this Series |
---|---|---|---|---|---|---|---|
1 | Janssen COVID-19 1-dose Series | 0 days | 18 years | 18 years | N/A | 212 | N/A |